L R Peterson
Overview
Explore the profile of L R Peterson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
241
Citations
3827
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chiang C, Chiang C, Chiang C, Ma K, Peng C, Hsia Y, et al.
Heart
. 2022 Nov;
109(6):470-477.
PMID: 36351793
Objectives: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce heart failure (HF) in at-risk patients and may possess antitumour effects. We examined the effect of SGLT2i on HF and mortality among patients with...
2.
Sletten A, Peterson L, Schaffer J
J Intern Med
. 2018 Jan;
284(5):478-491.
PMID: 29331057
Environmental and socioeconomic changes over the past thirty years have contributed to a dramatic rise in the worldwide prevalence of obesity. Heart disease is amongst the most serious health risks...
3.
Peterson L, Holsten J, Spevak P
Mem Cognit
. 2011 Feb;
3(3):243-6.
PMID: 21287067
Sequences of nine binary auditory signals (dots and dashes) were presented to 20 subjects in Experiment I. The subjects were instructed to internally organize the signals into two-dimensional arrays. Visual...
4.
Peterson L
Postgrad Med
. 2009 Aug;
109(2 Suppl):51-9.
PMID: 19667558
The fluoroquinolones are an important antimicrobial agent class that has been embraced by physicians and surgeons to the point that resistance in some bacterial strains has compromised their effectiveness. In...
5.
Wolk D, Picton E, Johnson D, Davis T, Pancholi P, Ginocchio C, et al.
J Clin Microbiol
. 2009 Jan;
47(3):758-64.
PMID: 19129414
The first U.S. multicenter clinical trial to assess the performance of the Cepheid Xpert MRSA assay (Xpert MRSA) was conducted. The assay is a qualitative test designed for the rapid...
6.
Peterson L
Clin Microbiol Infect
. 2008 Dec;
14 Suppl 6:30-45.
PMID: 19040464
Infectious diseases remain a serious and now re-emerging threat to human life, contributing to over ten million deaths per year. Treatment of major infectious diseases with antibacterial agents creates an...
7.
Peterson L
Clin Microbiol Infect
. 2007 Dec;
14 Suppl 1:181-4.
PMID: 18154544
Therapy of infections caused by extended-spectrum beta-lactamase (ESBL)-producing bacteria with an antimicrobial to which they are resistant results in treatment failure, higher cost and increased mortality. The CLSI recommends reporting...
8.
Peterson L
Clin Microbiol Infect
. 2005 Sep;
11 Suppl 5:4-16.
PMID: 16138814
The ongoing problem of emerging antimicrobial resistance has been likened to a balloon where settling one specific issue results in a 'bulge' of even worse problems. However, much has been...
9.
Trick W, Paule S, Cunningham S, Cordell R, Lankford M, Stosor V, et al.
Clin Infect Dis
. 2004 Mar;
38(6):780-6.
PMID: 14999619
Antimicrobial therapy can increase the colonization density of gastrointestinal vancomycin-resistant enterococci (VRE). Among previously VRE-colonized patients, we evaluated VRE colonization before and after initiation of antimicrobial therapy by means of...
10.
Gavin P, Suseno M, Cook F, Peterson L, Thomson Jr R
Diagn Microbiol Infect Dis
. 2003 Oct;
47(2):427-30.
PMID: 14522517
Medical treatment alone is rarely successful in left-sided infective endocarditis caused by Pseudomonas aeruginosa. We report the cure of such a case with high-dose meropenem in combination with tobramycin.